Evidence map›Paper›PMID 33802712›Full record

ArticleMaterials (Basel, Switzerland)2021

Clindamycin-Based 3D-Printed and Electrospun Coatings for Treatment of Implant-Related Infections.

Tina Maver, Tinkara Mastnak, Mihela Mihelič, Uroš Maver, Matjaž Finšgar

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tina MaverInstitute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Taborska ulica 8, SI 2000 Maribor, Slovenia.
Tinkara MastnakFaculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova ulica 17, SI 2000 Maribor, Slovenia.
Mihela MiheličFaculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova ulica 17, SI 2000 Maribor, Slovenia.
Uroš MaverInstitute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Taborska ulica 8, SI 2000 Maribor, Slovenia.ORCID 0000-0002-2237-3786
Matjaž FinšgarFaculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova ulica 17, SI 2000 Maribor, Slovenia.ORCID 0000-0002-8302-9284
University of Maribor · SI

Funding

Javna Agencija za Raziskovalno Dejavnost RS P2-0032, P3-0036, J1-2470, J2-1725, and J1-9169
6 · The paper itself

Abstract

This study presents the development and characterisation of two novel bioactive coatings deposited on TiAlV and AISI 316LVM substrates. The coatings were prepared using 3D printing and electrospinning. The 3D-printed coating consisted of the cellulose nanofibril suspension, alginate, and carboxymethylcellulose (CMC), while CMC and polyethylene oxide were used to prepare the electrospun coating. Both coatings were loaded with the antibiotic clindamycin (CLIN), which is a bacteriostatic lincosamide known for its activity against streptococci, staphylococci, pneumococci, Bacteroides species, and other anaerobes. Initial characterisation of the coatings was performed by attenuated total reflectance Fourier transform infrared spectroscopy, field emission scanning electron microscopy, and atomic force microscopy. Furthermore, the contact angle measurements, swelling rate, and biodegradability of the coatings were investigated. The released concentration of CLIN in PBS (pH = 7.4 at 25 °C) was determined by UV-VIS spectrophotometry. The coatings' biocompatibility was determined using an MTT (3(4,5 dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) assay using an osteoblast cell culture (hFOB 1.19, ATCC CRL 11372).

Indexed as

3D printed coatingAISI 316LVMbioactive coatingclindamycinelectrospun coatingTiAlV

Identifiers

PMID33802712
PMCPMC8002500
OpenAlexW3138823472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.